drugset / Trial / NCT02621164
Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and Adolescents
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study is a multi-center, randomized, double-blind Phase III clinical trial. The aim of the study is to describe the immunogenicity and safety of the quadrivalent cell culture-derived influenza vaccine compared to the trivalent egg-derived influenza vaccine among subjects.
Timeline
- Start
- 2014-09
- Primary completion
- 2015-02
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Agrippal S1 | Vaccine | 0.25 ml | Intramuscular |
| Comparator | Agrippal S1 | Vaccine | 0.5 ml | Intramuscular |
| Subject | NBP607-QIV | Vaccine | 0.25 ml | Intramuscular |
| Subject | NBP607-QIV | Vaccine | 0.5 ml | Intramuscular |